oxaliplatin
Showing 1 - 25 of 821
Immunotherapy Gastrict Cancer Trial (Tislelizumab, apatinib, oxaliplatin)
Not yet recruiting
- Immunotherapy Gastrict Cancer
- Tislelizumab
- +3 more
- (no location specified)
Jan 17, 2023
Elderly Metastatic Colorectal Cancer Patients Trial in Padua (Capecitabine, Oxaliplatin, Bevacizumab)
Active, not recruiting
- Elderly Metastatic Colorectal Cancer Patients
- Capecitabine
- +2 more
-
Padua, ItalyIstituto Oncologico Veneto IRCCS
Mar 30, 2022
Gastric Cancer Trial in Gyeonggi-do (Oxaliplatin, Capecitabine)
Recruiting
- Gastric Cancer
- Oxaliplatin
- Capecitabine
-
Gyeonggi-do, Korea, Republic ofHallym University Medical Center
Feb 4, 2022
Stage III Colon Cancer Trial in France (Oxaliplatin, Oxaliplatin LBM)
Active, not recruiting
- Stage III Colon Cancer
- Oxaliplatin
- Oxaliplatin LBM
-
Marseille, Bouches Du Rhône, France
- +10 more
Aug 2, 2022
Gastric Cancer Trial in Beijing (S-1, Trastuzumab, Oxaliplatin)
Completed
- Gastric Cancer
- S-1
- +3 more
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences
Aug 14, 2022
Colorectal Tumors Trial in Philadelphia (bevacizumab, cetuximab, Oxaliplatin)
Terminated
- Colorectal Neoplasms
- bevacizumab
- +3 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Dec 30, 2021
Gastric Cancer Trial in Mykolaiv (Docetaxel, Oxaliplatin, Leucovorin)
Active, not recruiting
- Gastric Cancer
- Docetaxel
- +4 more
-
Mykolaiv, UkraineUkrainian Society of Clinical Oncology
Apr 11, 2022
Gastric Cancer Stage IV Trial (Oxaliplatin, Levo-Leucovorin, 5-fluorouracil)
Not yet recruiting
- Gastric Cancer Stage IV
- Oxaliplatin
- +4 more
- (no location specified)
Apr 1, 2022
Immunotherapy, Gastrict Cancer Trial in Fuzhou (Tislelizumab, Apatinib Mesylate, oxaliplatin)
Recruiting
- Immunotherapy
- Gastrict Cancer
- Tislelizumab
- +3 more
-
Fuzhou, ChinaFujian cancer hospital
Jan 23, 2022
Rectal Cancer, Consolidation Trial in São Paulo (Oxaliplatin, 5FU)
Recruiting
- Rectal Cancer
- Consolidation
- Oxaliplatin
- 5FU
-
São Paulo, SP, BrazilHospital Alemão Oswaldo Cruz
Aug 3, 2021
Colorectal Adenocarcinoma, Mucinous Adenocarcinoma, Signet Ring Cell Adenocarcinoma Trial in Trondheim, Lørenskog, Oslo
Not yet recruiting
- Colorectal Adenocarcinoma
- +2 more
- Nivolumab
- Oxaliplatin
-
Trondheim, Trondelag, Norway
- +2 more
Aug 15, 2022
Metastatic Colorectal Cancer Trial in Herlev (Oxaliplatin, 5-Fluorouracil, Leucovorin)
Withdrawn
- Metastatic Colorectal Cancer
- Oxaliplatin
- +4 more
-
Herlev, DenmarkHerlev University Hospital, Department of Oncology
Oct 19, 2021
Colon Adenocarcinoma Trial in Sacramento (Carbon C 14 Oxaliplatin, Oxaliplatin)
Completed
- Colon Adenocarcinoma
- Carbon C 14 Oxaliplatin
- Oxaliplatin
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Mar 4, 2021
Biliary Tract Tumor Trial in Nanjing (Tislelizumab, Lenvatinib, Oxaliplatin)
Recruiting
- Biliary Tract Tumor
- Tislelizumab
- +3 more
-
Nanjing, Jiangsu, ChinaJiangsu Province Hospital
Mar 14, 2022
Gastric Cancer Trial in Jinan (SHR1210, Apatinib, S1)
Recruiting
- Gastric Cancer
- SHR1210
- +3 more
-
Jinan, Shandong, ChinaQilu hospital of Shandong univertisy
Mar 30, 2022
Colorectal Cancer, Peritoneal Metastases Trial in Sweden (5Fluorouracil, Irinotecan, Oxaliplatin)
Recruiting
- Colorectal Cancer
- Peritoneal Metastases
- 5Fluorouracil
- +2 more
-
Gothenburg, Sweden
- +3 more
Oct 12, 2021
Colorectal Cancer, Appendiceal Cancer, Peritoneal Carcinoma Trial in Salt Lake City (Oxaliplatin, mFOLFIRI)
Terminated
- Colorectal Cancer
- +2 more
- Oxaliplatin
- mFOLFIRI
-
Salt Lake City, UtahHuntsman Cancer Institute
Sep 21, 2021
Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou (Docetaxel,
Recruiting
- Metastatic Gastric Adenocarcinoma
- Metastatic Gastroesophageal Junction Adenocarcinoma
- Docetaxel
- +2 more
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated hosipital, Sun Yat-Sen University
Jan 20, 2022
Gastric Cancer, GastroEsophageal Cancer Trial in Beijing (SHR-1210, Capecitabine, Oxaliplatin)
Active, not recruiting
- Gastric Cancer
- GastroEsophageal Cancer
- SHR-1210
- +3 more
-
Beijing, Beijing, ChinaBeijing Cancer Hospital, Peking University
Aug 24, 2021
Phase II, Open-label, Parallel 2-arm, Multi-center Trial in Kaohsiung, Taichung, Tainan (Gemcitabine 1000 mg, Nab paclitaxel,
Recruiting
- Phase II, Open-label, Parallel 2-arm, Multi-center
- Gemcitabine 1000 mg
- +4 more
-
Kaohsiung, Taiwan
- +2 more
Jun 12, 2022
Metastatic Colorectal Carcinoma, Recurrent Colon Carcinoma, Refractory Colorectal Carcinoma Trial in Livingston, New Brunswick
Recruiting
- Metastatic Colorectal Carcinoma
- +5 more
- Oxaliplatin
- Trifluridine and Tipiracil Hydrochloride
-
Livingston, New Jersey
- +1 more
Mar 16, 2022
Colorectal Adenocarcinoma, Oesogastric Trial in France (Trifluridine/Tipiracil, Oxaliplatin)
Recruiting
- Colorectal Adenocarcinoma
- Oesogastric
- Trifluridine/Tipiracil
- Oxaliplatin
-
Besançon, France
- +10 more
Jan 28, 2022